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Abstract
Background: For chronic hemodialysis, the ideal permanent vascular access is the arteriovenous fistula (AVF).
Temporary catheters should be reserved for acute dialysis needs. The AVF is associated with lower infection rates,
better clinical results, and a higher quality of life and survival when compared to temporary catheters. In Brazil, the
proportion of patients with temporary catheters for more than 3 months from the beginning of therapy is used as
an evaluation of the quality of renal units. The aim of this study is to evaluate factors associated with the time
between the beginning of hemodialysis with temporary catheters and the placement of the first arteriovenous
fistula in Brazil.
Methods: This is an observational, prospective non-concurrent study using national administrative registries of all
patients financed by the public health system who began renal replacement therapy (RRT) between 2000 and 2004
in Brazil. Incident patients were eligible who had hemodialysis for the first time. Patients were excluded who: had
hemodialysis reportedly started after the date of death (inconsistent database); were younger than 18 years old;
had HIV; had no record of the first dialysis unit; and were dialyzed in units with less than twenty patients. To
evaluate individual and renal unit factors associated with the event of interest, the frailty model was used (N =
55,589).
Results: Among the 23,824 patients (42.9%) who underwent fistula placement in the period of the study, 18.2%
maintained the temporary catheter for more than three months until the fistula creation. The analysis identified
five statistically significant factors associated with longer time until first fistula: higher age (Hazard-risk - HR 0.99,
95% CI 0.99-1.00); having hypertension and cardiovascular diseases (HR 0.94, 95% CI 0.9-0.98) as the cause of
chronic renal disease; residing in capitals cities (HR 0.92, 95% CI 0.9-0.95) and certain regions in Brazil - South (HR
0.83, 95% CI 0.8-0.87), Midwest (HR 0.88, 95% CI 0.83-0.94), Northeast (HR 0.91, 95% CI 0.88-0.94), or North (HR 0.88,
95% CI 0.83-0.94) and the type of renal unit (public or private).
Conclusion: Monitoring the provision of arteriovenous fistulas in renal units could improve the care given to
patients with end stage renal disease.
Background
Chronic hemodialysis requires permanent vascular
access that can be used for months or years. The ideal
permanent vascular access is the arteriovenous fistula
(AVF). When AVF preparation is impossible, a graft can
be used. Temporary vascular access can be obtained
with cuffed or non-cuffed catheters. Catheters should be
reserved for acute dialysis, when immediate access is
needed, or for patients for whom permanent vascular
access is problematic [1,2].
Continuing use of temporary catheters in patients on
hemodialysis is the main concern of nephrologists in
several countries; proper patient care requires that an
AVF is functioning before renal replacement therapy
(RRT) needs to begin [2,3]. Fistulas are associated with
lower infection rates, lower hospitalization times and * Correspondence: gimacedosilva@hotmail.com
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increased survival, compared to temporary catheters
[4-8].
An AV fistula should be constructed at least 6 months
prior to dialysis in order to permit maturation; a graft
can be used after 3-6 weeks [2]. Regardless of the indivi-
dual factors that influence the creation of a permanent
vascular access, a temporary vascular access should be
the last option for initial access and should be replaced
by an AVF as soon as possible [2,3,8].
In Brazil, the proportion of patients with a temporary
vascular access for more than 3 months is used a quality
indicator for renal units, which are responsible for over-
seeing the placement of an AVF for their patients [9,10].
The National Kidney Foundation recommends that
catheter use as the vascular access should be decreased
to less than 10% of prevalent patients [2]. In Brazil in
2008, according to a study carried out by the Brazilian
Nephrology Society, 11.4% of patients on hemodialysis
had a catheter as the vascular access for hemodialysis
[11]. No study in Brazil has tried to investigate the pro-
longed use of a temporary catheter among patients who
started hemodialysis with this type of access.
Given the morbidity and mortality among patients
with end-stage renal disease (ESRD) due to prolonged
use of a temporary catheter, the aim of this study is to
investigate the factors associated with the time between
the beginning of hemodialytic treatment with a tempor-
ary catheter and the placement of the first AVF in Brazil
between 2000 and 2004.
Methods
Data and Population Sources for the Study
This is an observational, prospective, non-concurrent
study that used the National Database of RRT, which
contains patient records for the 2000-2004 period
[12,13]. This database was built using the subsystem
data of the High Complexity/Cost Procedures Authority
of the Outpatient Information System forms which are
administrative records of all complex procedures
financed by the Public Health System in Brazil. The
forms are mandatory and filled out by the dialysis provi-
ders. This database includes 95% of all chronic dialysis
patients in the country.
The total of incident patients in RRT from 01/01/2000
to 12/31/2004 who belonged to the National Database
of RRT was 90,356. Of these, 72,155 started on hemo-
dialysis. Two patients were excluded for whom hemo-
dialysis reportedly started after the date of death. Four
hundred and forty patients were excluded because of
HIV, 1,874 were excluded because they were younger
than 18 years old at baseline, 9,834 were excluded
because they had no record of their first hemodialysis
unit, and 4,416 because they were dialyzed in units with
less than twenty patients. Ultimately, this study included
55,589 subjects.
Patients who were dialyzed in renal units where the
number of patients was fewer than twenty were not
included, because these units are probably not renal
units, but hospitals that p r o v i d eo n l ye m e r g e n c y
hemodialysis.
Variables
The explanatory variables for each patient were sex, age,
city (capital or interior) and region of residence in Bra-
zil, cause of chronic renal disease (CKD) (glomerulone-
phritis, diabetes mellitus, hypertension and
cardiovascular diseases, undetermined cause), and iden-
tification of his or her first renal unit. Variables related
to the renal unit included: type (private vs. public), loca-
tion (hospital-based vs. satellite) and whether or not the
unit had rooms for outpatient surgeries.
As a response variable, the time, in months, between
the beginning of hemodialytic treatment with a tempor-
ary catheter and the creation of the first AVF was used.
In Brazil, the use of the arteriovenous vascular graft is
not common, so the AVF is probably the choice for per-
manent vascular access.
Statistical Analysis
A descriptive analysis was carried out, which included the
distributions of the frequencies and measures of the cen-
tral tendency. To check the association between the
response variable and the explanatory variables, a separate
curve of estimated survival was used for each explanatory
variable, using the Kaplan-Meier method. Verification of
the effect of each variable was evaluated using the Log-
Rank test, which allowed for the selection of variables to
build multiple models (p ≤ 0.05). Values for the median
times and their 95% confidence intervals were obtained.
The Cox Regression Model was used to evaluate the
individual factors associated with the time until the first
AVF procedure. In addition, differences among the renal
units represent an important factor in the quality of the
treatment provided to the patients. Therefore, consider-
ing that patients treated in the same unit would be
exposed to a common risk of occurrence for the event
of interest, the frailty model was applied. By means of
the inclusion of a random effect (frailty) at the renal
unit level, this model allowed for the insertion of expla-
natory variables related to these services that estimate
the patients’ risk for a given unit, in addition to correct-
ing for the effects of the other variables. The power of
association for survival models was demonstrated by the
hazard risk and the models’ respective 95% confidence
intervals [14].
W eu s e dt h es i g n i f i c a n c ev a l u eo ft h eu n i tv a r i a b l e s
and the likelihood ratio test to choose which unit
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model without frailty was tested with each unit variable
separately.
To compare the obtained survival models with and
without frailty, in addition to the theoretical hypothesis
that the renal services play a key role in providing qual-
ity care to these patients, the likelihood ratio test was
also used. The software R 2.12.1 was used for the statis-
tical analysis.
This investigation is part of the RRT Project, “Eco-
nomic-Epidemiologic Evaluation of the Renal Replace-
ment Therapy Modalities in Brazil,” developed by the
Health Economics Research Group of the Federal Uni-
versity of Minas Gerais, approved by the Ethics in
Research Committee of the Federal University of Minas
Gerais.
Results
The patients (N = 55,589) were distributed in 606 renal
units. The average age of the patients was 53.95 ± 16.01
years. Approximately 57% of these patients maintained a
temporary catheter until the censored date (end of the
study or date of dead or date of transplant). Among the
23,824 (42.9%) patients who underwent fistula place-
ment in the period of the study, 18.2% maintained the
temporary catheter for more than three months until
the fistula creation. The average time until the place-
ment of the first AVF for these patients (N = 23,824)
was 3 ± 6.26 months. Other characteristics are pre-
sented in Table 1.
In the univariate analysis, it was observed that 4 vari-
ables at the individual level and 3 variables at the renal
unit level were significantly associated with the time to
the first AVF (Table 2).
Table 3 shows the Cox models with and without
frailty. The value of the likelihood ratio test for the unit
variables tested in frailty models was 546 for the “type
of renal unit”,5 2 9f o rt h e“location” of these units and
459 for the “existence of rooms for outpatient surgeries”.
Thus, the unit-level variable that proved to be most
associated with the time until the placement of the first
AVF was the type of renal unit. The inclusion of frailty
in the model proved to be statistically significant and
led to an increase in the Likelihood Ratio Test statistic
from 398.8 to 546, showing the importance of evaluating
the influence of the renal units upon providing a perma-
nent vascular access and thus justifying the choice of the
frailty model.
Therefore, in the final model, the following variables
remained: age, cause of CKD, city, region of residence,
and type of renal unit.
It was observed that older patients tend to have an
approximately 1% lower probability for the placement of
the first AVF for each additional year. Patients with
hypertension and cardiovascular diseases as a cause of
CKD had a lower probability of permanent vascular
access by approximately 6% compared to patients with
glomerulonephritis.
Patients who lived in capital cities had an 8% lower
probability for the creation of the first AVF compared
to those who lived in the interior cities. Residents of the
South, Midwest, Northern, Northeast regions also had a
Table 1 Characteristics of incident hemodialysis patients
and renal units, National RRT Database, Brazil, 2000-
2004.
Variables N N %
(Valid)
Individuals 55,589 100.0
Socio-demographics
Sex
Male 31,925 57.4
Female 23,664 42.6
Year of entry
2000 10,957 19.7
2001 11,876 21.4
2002 12,452 22.4
2003 12,579 22.6
2004 7,725 13.9
Region of residence
Southeast 27,32 49.1
Northeast 13,779 24.8
South 8,844 15.9
Northern 2,701 4.9
Midwest 2,945 5,3
City of residence
Interior 35,579 64.0
Capital 18,312 32.9
Missing 1,698 3.1
Clinics
Cause of Chronic Kidney Disease
Undetermined 23,336 42.0
Hypertension and Cardiovascular
Diseases
13,824 24.9
Diabetes Mellitus 8,825 15.9
Glomerulonephritis 6,901 12.4
Others 2,703 4.9
Renal units 606 100
Type
Private 507 83.7
Public 99 16.3
Location
Hospital-based 247 40.8
Satellite unit 359 59.2
Existence of rooms for outpatient surgeries
Yes 186 30.7
No 420 69.3
Source: National RRT Database
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9%, respectively, in relation to the residents of the
Southeast.
It was observed that the frailty variance was signifi-
cant, indicating variability in the probability of occur-
rence of the event among renal units (0.55). Figure 1
shows the frailty estimates for the hazard risks for each
of the 606 renal units, which can be classified into 3
groups: frailties < 1, middle frailties, and frailties > 1.
Patients whose renal units had a frailty < 1 tended to
have longer waits for AVF surgery, whereas a frailty > 1
increased the probability of having surgery [14].
Discussion
In the present study, the proportion of patients on
hemodialysis who continued to use the catheter for a
period > 3 months was still above the recommended
level, as reported in Sesso et al. (2008) [2,11]. Several
countries have made efforts to reduce this proportion,
such as the United States, where one third of patients
are still on dialysis with a catheter after 6 months from
the beginning of treatment [6,8,15]. Among European
countries, differences in catheter use can also be
observed, though some are close to, or have already
reached, the established practice standards [8].
The average time until AVF placement in our study
was greater than that found in the study by Linardi et
al. (2004), whose estimate varied from 1 to 3 weeks for
Brazil [16]. The study by Either et al. (2008) reported
that the minimum time was 5 days for Italy and 43 days
for the United Kingdom [8].
The results of this analysis indicated 4 individual fac-
tors that were associated with the time until the first
AVF procedure: age; having hypertension and cardiovas-
cular diseases or undetermined cause as causes of CKD;
residing in capital cities; and residence in certain regions
of Brazil (South, Midwest, North, and Northeast
regions). These associations remained significant even
Table 2 Association between time to first fistula placement and explanatory variables, Brazil, 2000-2004†.
Explanatory variables Median 95% CI p-value*
Level 1: Individuals
Sex 0.51
Male 30.2 ± 0.2 29.8-30.5
Female 29.4 ± 0.2 29-29.8
Cause of Chronic Kidney Disease 0.000*
Glomerulonephritis 1.73 ± 0.005 1.72-1.74
Diabetes Mellitus 1.76 ± 0.004 1.76-1.77
Hypertension and Cardiovascular Diseases 1.75 ± 0.004 1.74-1.75
Undetermined and others 1.76 ± 0.003 1.76-1.77
City of residence 0.000*
Interior 1.75 ± 0.002 1.75-1.75
Capital 1.76 ± 0.003 1.75-1.76
Region of residence 0.000*
South 1.78 ± 0.004 1.78-1.79
Northeast 1.76 ± 0.004 1.75-1.77
North 1.77 ± 0.008 1.76-1.79
Southeast 1.74 ± 0.003 1.74-1.75
Midwest 1.77 ± 0.008 1.75-1.78
Level 2: Dialysis units
Type of provider 0.000*
Private 1.75 ± 0.002 1.75-1.75
Public 1.78 ± 0.005 1.77-1.79
Location 0.000*
Hospital-based 1.78 ± 0.003 1.77-1.78
Satellite 1.74 ± 0.002 1.74-1.75
Existence of rooms for outpatient surgeries 0.000*
Yes 1.77 ± 0.003 1.77-1.78
No 1.75 ± 0.002 1.74-1.75
† To survival analysis was used Kaplan-meyer
*p≤ 0.05 (Log-rank test)
Source: National RRT Database
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(type of renal unit).
Increasing age was associated with longer times with
temporary catheters, possibly because older patients
were more likely to have vascular disease, making fistu-
las more difficult to establish, as suggested by several
authors [4,15,17]. Reddan et al. (2002) suggest that AVF
failure rates may be increased in older patients [17]. On
the other hand, Stehman-Brenn et al. (2000) point out
that older age does not necessarily result in poorer
patency outcomes [15].
Hypertension was associated with a lower probability
for the AVF procedure in relation to glomerulonephritis,
in agreement with other studies that address hyperten-
sion [18]. This proposition is plausible for Brazil, where
hypertensive patients face difficulties in obtaining pre-
dialysis care, which reduces their chances of having a
mature access at the time of dialysis [19].
The present study also found that patients who lived
in capital cities had a lower probability of having timely
performance of fistula surgery. A study by Osis et al.
(1993) found a higher use of services by the inhabitants
of the interior cities (medical appointments) which may
be associated with differences in the access to care [20].
Therefore, for our study, residing in interior cities could
result in less competition for the performance of the
outpatient procedure. However, another study diverges
from this finding and reports easier access for the inha-
bitants of the capitals, indicating that these cities may
have a higher technological density and capacity [21].
Brazil is divided into five regions: Southeast, South,
Midwest, Northern and Northeast. This division empha-
sizes a historical and spatial perspective, referring to
economic and social characteristics and political organi-
zation of the national space [22]. The differences found
among the regions of Brazil point to differences in
access to health care in the country. Coelho et al. (2006)
point to a large discrepancy in the health indicators
among the South and Southeast regions, which present
better results, and the Northern and Northeast regions,
Table 3 Cox models for time to first fistula placement, Brazil, 2000-2004.
No Frailty Frailty
Explanatory variables Hazard-risk 95% CI p-value Hazard-risk 95% CI p-value
Individuals
Age 0.99 0.99-1.00 * 0.99 0.99-1.00 *
Cause of Chronic Renal Disease †
Diabetes Mellitus 1.02 0.98-1.07 0.34 1.01 0.96-1.06 0.68
Hypertension and Cardiovascular Diseases 0.94 0.90-0.99 * 0.94 0.90-0.98 *
Undetermined and others 0.91 0.88-0.95 * 0.91 0.87-0.95 *
City of residence †
Interior 0.91 0.89-0.94 * 0.92 0.90-0.95 *
Region of residence†
South 0.85 0.82-0.88 * 0.83 0.80-0.87 *
Midwest 0.88 0.82-0.93 * 0.88 0.83-0.94 *
North 0.89 0.83-0.95 * 0.88 0.83-0.94 *
Northeast 0.91 0.89-0.94 * 0.91 0.88-0.94 *
Renal units
Type of renal unit (frailty variable)
Likelihood Ratio Test 398.8 546
Frailty variance - 0.55
Source: National RRT Database
† Reference categories respectively: glomerulonephritis, capital and Southeast.
*p ≤ 0.05
Figure 1 “Risks of renal units and their 95% CI to first fistula
placement, Brazil, 2000-2004”. This figure shows an estimative of
frailty risks of renal units and their respective 95% confidence intervals
of the time to completion of the first fistula, Brazil, 2000-2004.
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vices [21]. The analysis carried out by Cazelli et al.
(2002) also revealed differences among the regions in
the availability of high complexity equipment, where the
Northern and Northeast regions showed lower coverage
than the national average [23].
Lima et al. (2002) suggests that one of the factors
related to the differences found in the access to and use
of health services among the regions may be the differ-
ences in the size and complexity of the service networks,
which influence their availability [24].
Studies conducted in England and the United States
also found a wide variability in the use of the AVF
among different geographic regions of the countries,
suggesting that this variation reflects differences in the
practice standards adopted by nephrologists and vascu-
lar surgeons or renal unit teams; it may also suggest dis-
crepancies between the offer and demand for renal units
and the variations in the type or quality of the services
offered [4,25,26].
The variations observed in the time until placement of
AVF were associated with the type of renal units. This
allows for the identification of an association between
t h er e n a ls e r v i c ea n dt h ep r o v i s i o no ft h ef i s t u l a ,w h i c h
can be related to differences in the practice standards of
these services [14]. The variation found among the renal
units confirms the importance of including evaluations
of these services to identify points of reference for pub-
lic policies that can impact the quality of health care for
ESRD patients.
Linardi et al. (2003) found variations in catheter use
among renal units that were distributed among 7 Brazi-
lian states and suspected that structural differences
among units, such as the location of the clinic in rela-
tion to the regional reference hospital, could influence
the patients’ profiles [27].
A study by Allon et al. (2000) also showed differences
in the prevalence of fistulas among different renal units
in a metropolitan area of the United States. However,
the data collected in this study did not allow an evalua-
tion the reasons of this variability, and stated that speci-
fic renal units have been able to increase the fistula
frequency through the implementation of their own
efforts [4].
Limitations inherent in the use of an administrative
database should be considered for the present investiga-
tion because factors such as socioeconomic level, race
or ethnicity, and co-morbid conditions could not be
investigated. In addition, we used the dependent variable
of the date of fistula surgery, and not the date of cathe-
ter removal, because in the National Database of RRT
there are only the dates of the creation of the first AVF.
However, we must consider that the date of catheter
removal would be more clinically relevant, because even
a successful fistula will not go into service for 6-8 weeks
and many fistulas do not mature. Thus, the proportion
of those with the first AVF surgery included some
patients who have had their first surgeries but for whom
the maturation of the AVF “failed”.
The patients who had an undetermined cause for
CKD were not excluded from the analysis because, as
suggested by Moura et al. (2009), the exclusion of
patients with this condition (42%) could compromise
the present investigation [28]. Moreover, this study
showed a deficiency in this subsystem of the Brazilian
Public Health System for recording the causes of CKD.
The proportion found in this study and in Sesso et al.
(2008) was practically double the proportion reported in
Spain and is higher than the proportion in the United
States [11,15,18,29].
Conclusion
The differences in the probability of time until the first
fistula placement detected in this investigation were
associated with individual characteristics and with the
renal units where hemodialysis was performed. These
associations reinforce the need to include monitoring of
the provision of permanent vascular access in renal
units to evaluate the quality of these services (it is an
essential quality indicator of health care), with the objec-
tive of obtaining better results in the care provided by
the Brazilian Public Health System to patients with
CKD. Future investigations that further evaluate these
services are of great importance for the improvement of
patient care.
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